HomeStock ScreenerPhaarmasia

Phaarmasia Share Price | Phaarmasia Stock Screener

PHRMASI Pharmaceuticals
Share Price BSE
₹84.50
▼ -0.39 (-0.46%)
2026-05-19 00:00:00
As of May 19, 2026, the Phaarmasia share price (BSE: PHRMASI) is ₹84.50, down 0.46% from the previous close, with shares trading between ₹84.50 and ₹84.89, and a 52-week range of ₹26.40–₹129.20. Check PHRMASI price range for the annual price range and momentum. Use the Phaarmasia stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Phaarmasia Market Cap ₹61.03 Cr.
PHRMASI P/E Ratio (TTM) 3.45
Phaarmasia P/B Ratio 9.42
EPS (TTM) ₹-2.33
Dividend Yield -
Debt to Equity 0.01
PHRMASI 52 Week High ₹129.20
Phaarmasia 52 Week Low ₹26.40
Operating Margin 1.00%
Profit Margin 27.69%
PHRMASI Revenue (TTM) ₹65.00
EBITDA ₹22.00
Net Income ₹18.00
Total Assets ₹22.00
Total Equity ₹9.00

Phaarmasia Share Price Chart

Screen Phaarmasia share price with an interactive chart. Analyse PHRMASI price trends and volatility across different timeframes.

Phaarmasia Company Profile - Fundamental Screener

Screen Phaarmasia company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PHRMASI shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE486I01016

Phaarmasia Balance Sheet Screener

Screen PHRMASI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 22 31 28 21 22 34 33 22 20 19
Current Assets 8 18 15 8 9 20 19 8 6 4
Fixed Assets 12 13 13 13 13 13 14 14 14 14
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 1 1 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 9 10 11 12 14 13 13 12 12 12
Share Capital 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 2 4 4 5 7 7 6 5 5 5

Phaarmasia Income Statement Screener - Profit & Revenue Analysis

Screen Phaarmasia income statement and profit fundamentals. Analyze PHRMASI quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Phaarmasia share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 65 25 31 28 18 21 25 25 21 15 22 19
Expenses 43 26 31 29 19 20 24 24 20 14 21 18
EBITDA 22 -1 0 -1 -1 1 1 1 1 1 1 1
Operating Profit % 1.00% -8.00% -3.00% -6.00% -10.00% 0.00% 3.00% 3.00% 3.00% 1.00% 1.00% 5.00%
Depreciation 0 0 0 0 0 0 0 1 1 0 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 21 -2 -1 -1 -2 1 1 1 1 0 0 0
Tax 4 0 0 0 0 0 0 0 0 0 0 0
Net Profit 18 -2 -1 -1 -2 0 1 1 1 0 0 0
EPS 26.00 -2.33 -0.76 -1.84 -2.27 0.46 0.79 1.14 0.84 0.24 0.06 0.20

Phaarmasia Cash Flow Screener - Liquidity Fundamentals

Screen PHRMASI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 0 0 1 0 0 0 0 1 0 0
Investing Activities 0 0 0 0 0 0 0 -1 0 0
Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 1 0 0 0 0 0 0 0

Phaarmasia Shareholding Pattern Screener

See Phaarmasia shareholding pattern with promoter, FII, and DII holdings. Check Phaarmasia promoter holding and ownership changes for PHRMASI on TickJournal.
Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun
Promoter Holding 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.06% 0.05% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 25.66% 25.81% 25.82% 25.82% 26.18% 26.18% 26.18% 26.18%
Other Holding 0.76% 0.62% 0.61% 0.60% 0.25% 0.25% 0.25% 0.25%
Shareholder Count 20,301 20,404 20,497 20,512 20,620 20,612 20,596 20,642

Phaarmasia Share Dividend Screener - Share Yield Analysis

Check Phaarmasia dividend history with payout and yield data. View Phaarmasia dividend details including ex-dates and amounts for PHRMASI stock.
No dividends declared by Phaarmasia.

Phaarmasia Stock Index Membership

See which indices include Phaarmasia stock. Check PHRMASI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Phaarmasia is not part of any tracked indices.
Only major market indices are tracked in our system.

Phaarmasia Market Events Screener - Corporate Actions

Get Phaarmasia corporate actions including splits, bonuses, and buybacks. Check Phaarmasia stock events that may affect PHRMASI share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 23.19%
Annual General Meeting NA 17.28%
2026-02-06 2026-02-06 Quarterly Result Announcement NA -0.30%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -2.94%
2025-08-11 2025-08-11 Quarterly Result Announcement NA 0.00%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -2.44%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -4.52%
2024-11-05 2024-11-05 Quarterly Result Announcement NA 4.89%

Phaarmasia Competitors Screener - Peer Comparison

Screen PHRMASI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 450,643 40.81 54,729 9.71% 10,980 64.89
Divis Laboratories 179,470 74.13 9,712 18.67% 2,191 64.06
Torrent Pharmaceuticals 149,109 65.68 11,539 6.99% 1,911 58.52
Cipla 115,682 30.09 27,712 -2.46% 3,783 69.78
Dr Reddys Laboratories 111,567 26.16 33,593 -0.44% 3,998 59.87
Lupin 104,032 19.28 27,488 19.98% 5,345 46.11
Mankind Pharma 103,325 56.36 12,744 20.90% 2,007 73.37
Zydus Life Science 101,801 19.85 23,511 18.55% 4,615 69.47
Aurobindo Pharma 87,806 25.16 32,346 9.43% 3,484 73.83
Laurus Labs 71,455 79.78 6,813 21.03% 884 80.26

Phaarmasia Company Announcements - News Screener

Screen PHRMASI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-17 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-15 Announcement Under Reg-30_Clarification -
2026-04-15 Announcement under Regulation 30 (LODR)-Change in Registered Office Address -
2026-04-13 Clarification sought from Phaarmasia Ltd -
2026-03-27 Closure of Trading Window -
2026-02-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-06 Integrated Financials For The Quarter Ended 31St December 2025 -
2026-02-06 Results-Financial Results For The Quarter Ended 31St December 2025 -
2026-02-06 Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 06Th February 2026 At 05.00 PM -
2026-02-02 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday 6Th February 2026. -
2026-01-16 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-29 Closure of Trading Window -
2025-11-15 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-14 Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025 -
2025-11-14 Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025 -
2025-11-14 Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th November 2025 To Approve The Unaudited Financial Statement For The Quarter And Half Year Ended 30Th September 2025. -
2025-11-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-07 Board Meeting Intimation for Notice Of 05Th Board Meeting Of Phaarmasia Limited Scheduled To Be Held On Friday 14Th November 2025 At 05.00 PM(IST). -
2025-10-18 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-10-13 Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th October 2025 -